Publications
Detailed Information
2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shin, Jinho | - |
| dc.contributor.author | Park, Jeong Bae | - |
| dc.contributor.author | Kim, Kwang-il | - |
| dc.contributor.author | Kim, Ju Han | - |
| dc.contributor.author | Yang, Dong Heon | - |
| dc.contributor.author | Pyun, Wook Bum | - |
| dc.contributor.author | Kim, Young Gweon | - |
| dc.contributor.author | Kim, Gheun-Ho | - |
| dc.contributor.author | Chae, Shung Chull | - |
| dc.contributor.author | The Guideline Committee of the Korean Society of Hypertension | - |
| dc.date.accessioned | 2017-02-01T02:22:58Z | - |
| dc.date.available | 2017-02-01T02:22:58Z | - |
| dc.date.issued | 2015-04-08 | - |
| dc.identifier.citation | Clinical Hypertension, 21(1):2 | ko_KR |
| dc.identifier.uri | https://hdl.handle.net/10371/100349 | - |
| dc.description | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. | ko_KR |
| dc.description.abstract | Treatment strategies are provided in accordance with the level of global cardiovascular risk, from lifestyle modification in the lower risk group to more comprehensive treatment in the higher risk group. Considering the common trend of combination drug regimen, the choice of the first drug is suggested more liberally according to the physicians discretion. | ko_KR |
| dc.language.iso | en | ko_KR |
| dc.publisher | BioMed Central | ko_KR |
| dc.subject | Antihypertensive treatment | ko_KR |
| dc.subject | Cardiovascular risk | ko_KR |
| dc.subject | Guidelines | ko_KR |
| dc.subject | Hypertension | ko_KR |
| dc.subject | Lifestyle | ko_KR |
| dc.subject | Organ damage | ko_KR |
| dc.title | 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension | ko_KR |
| dc.type | Article | ko_KR |
| dc.contributor.AlternativeAuthor | 신진호 | - |
| dc.contributor.AlternativeAuthor | 박정배 | - |
| dc.contributor.AlternativeAuthor | 김광일 | - |
| dc.contributor.AlternativeAuthor | 김주한 | - |
| dc.contributor.AlternativeAuthor | 양동헌 | - |
| dc.contributor.AlternativeAuthor | 편욱범 | - |
| dc.contributor.AlternativeAuthor | 김영권 | - |
| dc.contributor.AlternativeAuthor | 김권호 | - |
| dc.contributor.AlternativeAuthor | 채성철 | - |
| dc.identifier.doi | 10.1186/s40885-014-0013-2 | - |
| dc.language.rfc3066 | en | - |
| dc.rights.holder | Shin et al.; licensee BioMed Central. | - |
| dc.date.updated | 2017-01-06T10:56:47Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.